Clinical Trials Browser

Withdrawn × OTHER × nilotinib × Clear all

NCT02973711 2021-02-16

A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML

Phase 1/2 Withdrawn

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02421926 2019-07-08

IDEAL-E

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02774512 2017-10-06

ZAK-0

Phase EARLY_PHASE1 Withdrawn

Gastrointestinal

Colonic Neoplasms

NCT01270893 2012-08-02

Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST)

Phase 2 Withdrawn

GastrointestinalSarcoma

Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors